Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD20A17P is a human pseudogene from the ankyrin repeat domain 20 family. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional; they arise from gene duplication or retrotransposition. ANKRD20A17P does not encode a functional protein and has no recognized biological roles, disease association, or relevance as a drug target or biomarker. Not a therapeutic target; cannot be manipulated by drugs, antibodies, or other biologics for therapeutic effect. No protein product; does not participate in cell signaling, metabolism, or any biological pathway like functional members of the ankyrin repeat domain family. No known disease relevance; not associated with human disease nor considered a biomarker. If you require information about a functional ankyrin repeat domain-containing protein as a therapeutic target (e.g., ANKRD17, ANKRD1), please specify, as this entry is a pseudogene and not a valid target for drug discovery or translational research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 20 family member A17, pseudogene (ANKRD20A17P).